Referenser

ACPO Drugs Committee (2002), A review of drugs policy and proposals for the future, The Association of Chief Police Officers, London.

Bossong, M.G., Van Dijk, J.P. and Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), s. 321–3.

Burrell, K., Jones, L., Sumnall, H. et al. (2005), Tiered asroach to drug prevention and treatment among young people, National Collaborating Centre for Drug Prevention, Liverpool.

Chen, C.-Y., O’Brien, M.S. and Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000–2001’, Drug and alcohol dependence 79, s. 11–22.

Chivite-Matthews, N., Richardson, A., O’Shea, J. et al. (2005), Drug misuse declared: findings from the 2003/04 British Crime Survey. Home Office statistical bulletin 04/05, Home Office, London (http://www.homeoffice.gov.uk/rds/pdfs05/hosb0405.pdf).

CND (2005), World drug situation with regard to drug trafficking: Report of the Secretariat, Kommissionen för narkotiska droger, Förenta nationernas ekonomiska och sociala råd, Wien.

CND (2006), World drug situation with regard to drug trafficking: Report of the Secretariat, Kommissionen för narkotiska droger, Förenta nationernas ekonomiska och sociala råd, Wien.

ECNN (2002a), Prosecution of drug users in Europe – varying pathways to similar objectives, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2002b), 'Mortality of drug users in the EU: coordination of implementation of new cohort studies, follow-up and analysis of existing cohorts and development of new methods and outputs', Project CT.00.EP.13, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2004a), 2004 Situationen på narkotikaområdet i Europeiska unionen och Norge, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2004b), An overview of cannabis potency in Europe, Insights no. 6, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2004c), European report on drug consumption rooms, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2004d), 'Overdose: a major cause of avoidable death among young people', Drugs in Focus No. 13, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2005a), Årsrapport 2005: situationen på narkotikaområdet i Europa, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2005b),'Assistance to EMCDDA for the analysis of drug profiles from EMCDDA Databank on surveys of drug use', final report, project CT.03.P1.200, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

ECNN (2005c), 'Data collection to develop an inventory of social and health policies, measures and actions concerning drug users in prison in the recently incorporated Member States to the EU', final report, project CT.04.P2.329, Europeiska centrumet för kontroll av narkotika och narkotikamissbruk, Lissabon.

EuroHIV (2005), HIV/AIDS surveillance in Europe: End-year report 2004. Institute de veille sanitaire: Saint-Maurice. No 71.

Europol (2006), 'Drugs 2006' (communication to the EMCDDA of 16 January 2006, file no. 158448), Europol, Haag.

Farrell, M., Gowing, L., Marsden, J. et al. (2005), 'Effectiveness of drug dependence treatment in HIV prevention', International journal of drug policy 16S, s. S67–75.

Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), 'Relationship between cocaine use and mental health problems in a sample of European cocaine powder and crack users', World psychiatry, 4(3), s. 173-6.

Hibell, B., Andersson, B., Bjarnasson, T. et al. (2004), The ESPAD report 2003: alcohol and other drug use among students in 35 European countries, Centralförbundet för alkohol- och narkotikaupplysning (CAN) och Europarådets Pompidougrupp.

Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, s. 1043–52.

INCB (2006a), Report of the International Narcotics Control Board for 2005, Internationella narkotikakontrollstyrelsen, New York.

INCB (2006b), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, Internationella narkotikakontrollstyrelsen, New York.

Kandel, D. and Davis, M. (1992), 'Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use', in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse s. 211–53. American Psychological Association. Washington.

Kumpfer, K.L., Molgaard, V. and Spoth, R. (1996), 'The Strengthening Families Program for prevention of delinquency and drug use in special populations', in: Peters, R. and McMahon, R. J. (eds) Childhood disorders, substance abuse, and delinquency: prevention and early intervention asroaches, Sage Publications, Newbury Park, CA.

MacDonald, Z., Tinsley, L., Collingwood, J. et al. (2005), Measuring the harm from illegal drugs using the drug harm index. Home Office Online Report 24/05. Home Office, London (http://www.homeoffice.gov.uk/rds/pdfs05/rdsolr2405.pdf).

Naber, D. and Haasen, C. (2006), Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger – eine multizentrische, randomisierte, kontrollierte Therapiestudie, Hamburg: Zentrum für interdisziplinäre Suchtforschung der Universität Hamburg (http://www.heroinstudie.de/ZIS_H-Bericht_P1_DLR.pdf).

ONS (2006), Health Statistics Quarterly 29, Office for National Statistics, London.

Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, s. 219–28.

Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), 'Cocaine use in Europe – a multi-centre study: patterns of use in different groups', European addiction research 10, s.147–55.

Nationella Reitoxrapporter (2005) (http://www.emcdda.europa.eu/?nnodeid=435).

Roe, E. and Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), s. 85–99.

Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement asroach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, s. 1–13.

Schäfer, C. and Paoli, L. (2006), Drogenkonsum und Strafverfolgungspraxis, Duncker & Humblot, Berlin.

Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, s. 340–9.

Shearer, J. and Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, s. 203–11.

UNODC (2003a), Global illicit drug trends 2003, FN:s organ för narkotika- och brottslighetsfrågor, Wien.

UNODC (2003b), Ecstasy and amphetamines: global survey 2003, FN:s organ för narkotika- och brottslighetsfrågor, Wien.

UNODC (2005), Coca cultivation in the Andean region: A survey of Bolivia, Colombia and Peru – June 2005, FN:s organ för narkotika- och brottslighetsfrågor, Wien.

UNODC (2006), 2006 world drug report, FN:s organ för narkotika- och brottslighetsfrågor, Wien.

UNODC and Government of Morocco (2005), Morocco Cannabis Survey 2004. FN:s organ för narkotika- och brottslighetsfrågor, Wien.

Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), s. 196–8.

Vickerman, P., Hickman, M., Rhodes, T. and Watts, C. (2006), ‘Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users’, Journal of Acquired Immune Deficiency Syndromes (in press).

Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), s. 49–64.

WCO (2005), Customs and drugs 2004, Världstullorganisationen, Bryssel.

WHO (2005), Effectiveness of drug dependence treatment in preventing HIV among injecting drug users. Evidence for action technical papers, Världshälsoorganisationen, Genève.

WHO/UNODC/UNAIDS (2004), 'Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention', position paper, WHO, UNODOC, UNAIDS (http://www.who.int/substance_abuse/publications/treatment/en/index.html).